First, we assessed whether the cellular expression of CD204+ or CD163+ M2‐TAM correlated with the STAT3/NF‐κB signaling pathways in the tumor microenvironment (TME) of 95 patients with cervical cancer (Table1 and Figure 2). The gene discussed is NFKB1; the disease is cervical cancer.